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Veterinary Diagnostic Ultrasonography
N. Sydney Moise, D .V .M ., D .A .C .V .I.M .
P rim u m  n o n  nocere.
Latin. First do no harm.
As veterinary clinicians we usually relate 
this ancient rule of medicine to the ther­
apeutic intervention of disease; however, 
we are often aware of this statement's 
truth concerning diagnostic procedures. 
During our daily veterinary practice we 
are reminded that many of the necessary 
diagnostic tests we perform subject ani­
mals to a certain amount of stress, and 
sometimes danger. As feline practitioners 
we are even more cognizant of this fac­
tor. Since a cat is small, many invasive 
procedures are more difficult than in the 
dog. Also, a cat's apprehensive tempera­
ment often necessitates chemical 
restraint. Therefore, a noninvasive, 
painless way for reaching a diagnosis is 
desired.
Ultrasonography can provide this means 
in many situations. For example, to 
characterize the type of cardiomyopathy 
that a cat possesses as either dilated, 
hypertrophic, or restrictive, an angiogram 
is usually required, since electrocardio­
grams and radiographs do not render a 
specific classification. Therapy and 
prognosis are dependent on the correct 
diagnosis. Ultrasonography can give the 
definitive diagnosis because the heart 
walls and chambers may actually be seen 
and their size measured. Also, the 
contractility of the heart can be accu­
rately assessed. This vital information 
can be obtained with ultrasonography with­
out the pain, anesthesia, catheterization, 
dye injection, or radiation involved with 
angiography.
The use of diagnostic ultrasound in 
veterinary medicine promises to be a 
rewarding and exciting endeavor. However, 
as with any diagnostic aid, ultrasonogra­
phy is just that - an aid to the proper 
diagnosis. The foremost restriction is 
availability due to high cost. Despite 
any drawback that this new venture in 
veterinary medicine may have, an awareness 
of ultrasonography on the part of veteri­
narians is important.
The basic principle behind ultrason­
ography involves the use of high frequency 
sound waves directed toward soft tissue 
structures, the reflection of these waves 
as they hit interfaces of soft tissues, 
and the processing of the returned sound 
waves to form a meaningful picture. An 
ultrasound unit or echograph sends and 
receives millions of ultrasound waves 
through a hand-held transducer. The 
transducer contains a synthetic crystal 
that possesses the property of piezoelec­
tricity. The piezoelectric property means 
that a material has the ability to convert 
electrical signals into mechanical vibra­
tions and vice versa. Thus, nonaudible 
sound waves (ultrasound) are produced. 
The transducer can send and receive these 
ultrasound waves. Some of the ultrasound 
waves sent from the transducer bounce back 
once they hit a boundary between tissues 
that transmit sound differently. An exam­
ple of such a boundary is the interface 
between the blood and wall of a heart 
chamber. The sound waves that are bounced 
back are converted back to electrical 
energy and then to a picture which is 
displayed on the video screen. Since 
sound waves do not easily penetrate bone
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or easily travel through gas-filled 
structures (e.g., lung, gaseous loops of 
bowel), examinations are limited to fluid 
density soft tissue organs and structures 
(heart, liver, kidney, etc.). When per­
forming an ultrasound examination, the 
transducer is placed against the skin of 
the animal and directed toward the organ 
to be scanned. As the transducer is 
moved, different structures appear on the 
echograph's screen.
Echographs have been used for over 
three decades in human medicine. However, 
the technology has evolved to a highly 
sophisticated form in the past decade, and 
the advances being made today are tremen­
dous.
The two modes of ultrasound most 
commonly employed today are M-mode (motion 
mode) echocardiography and two-dimensional 
(2-D) ultrasonography. M-mode echocardi­
ography is used to evaluate the heart. 
This form of ultrasonography allows a 
study of the heart walls, valves, and 
chambers. The size of these structures 
can be measured and their motion evalu­
ated. With M-mode echocardiograms a 
single beam of ultrasound is directed 
toward the heart. To the untrained eye, 
the resulting images appear merely as 
numerous moving lines; however, once 
interpretation of the echogram is mas­
tered, a wealth of information can be 
retrieved. This form of ultrasound has 
been and continues to be used principally 
by cardiologists. With the development of 
2-D ultrasonography, a more complete 
picture of the heart and other soft tis­
sues can be obtained. A more complete 
image is possible because instead of using 
a single sound beam, multiple ultrasound 
waves are directed over a greater area of 
the studied organ. This is accomplished 
by rapidly moving the single beam (mechan­
ical transducer) or by numerous lined 
single beams (linear transducer) or by 
lined electronically fired sound beams 
(phased array transducer). Two-dimension­
al ultrasonography produces a picture that 
is much more understandable to the 
untrained eye and an increased amount of
information may be obtained. Many of the 
commercial ultrasound units marketed today 
for cardiac studies incorporate both
M-mode and 2-D ultrasound.
What diagnoses are possible with ultra­
sonography? The following are some
examples of what can be seen with 2-D 
ultrasonography: congenital heart defects 
(ventricular septal defect, tetralogy of 
Fallot, pulmonic and aortic stenosis,
etc.); cardiac valvular lesions; cardio­
myopathies; intracardiac masses; heart­
worms; polycystic kidneys; hydronephrosis; 
renal calculi; renal masses (parenchymal 
and pelvic); cystic calculi (urinary
bladder and gall bladder); enlarged, 
obstructed gall bladder; hepatic masses; 
portocaval shunts; prostatic disease; 
pregnancy determination; and abdominal 
mass identification (i.e., mesenteric mass 
vs. splenic mass). In addition, biopsy of 
tissues can be guided by ultrasound; 
therefore, nonsurgical biopsies no longer 
have to be done "blindly."
The exciting aspect of ultrasonography 
is that the diagnoses listed above can be 
made noninvasively, without subjecting the 
animal to pain, stress, or danger. Also, 
studies may be repeated over and over 
again without risk. Repetition is
possible because the procedure does not 
harm the patient, and we as the instrument 
operators are not exposed to any hazards, 
such as radiation.
What are the disadvantages of ultra­
sound? At this point excessive cost is 
the most inhibiting factor to the advance­
ment of veterinary ultrasonography. Used 
M-mode echographs are becoming available 
at more affordable prices ($500-$5,000) as 
human hospitals discard their older units 
and replace them with combination M-mode/ 
2-D units. The disadvantage of the 
"M-mode only" echograph, as stated, is 
that the scanning is limited to the heart.
Some companies are now producing lower 
cost 2-D ultrasound units for the veteri­
nary market. However, although a couple
(Continued on page 7.)
3Dr. Fernando de Noronha Leads FeLV Research Team
Fernando de Noronha, D.V.M., Professor of 
Virology and viral oncology laboratory 
chief, recently received an annual alloca­
tion of $105,454 from the National 
Institutes of Health for his research 
entitled "Serotherapy of Virus-Induced
Sarcoma or Leukemia." This most recent
award is a continuation of a three-year 
grant, and the latest milestone in Dr. de 
Noronha's 20-year history of investigating 
feline leukemia virus (FeLV) and feline 
sarcoma virus (FeSV).
Serotherapeutic techniques developed 
during his current project have produced 
FeLV/FeSV tumor regression in approximate­
ly 70% of the experimental cases. These 
techniques have involved the use of heter­
ologous and homologous sera from hyper­
immunized animals directed against the 
FeLV glycoprotein gp70, the target antigen 
for FeLV-neutralizing antibody. Recently 
Dr. de Noronha's laboratory developed a 
panel of monoclonal antibodies directed 
against gp70. Because this glycoprotein 
is expressed on the surface of FeLV parti­
cles and also on the surface of FeLV-
infected cells, they plan a new approach
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which will involve tagging of anti-gp70 
monoclonal antibodies with toxins such as 
ricin. These tagged antibodies will then 
be used as "bullets" against the FeLV- 
infected cells. This procedure, unlike 
chemotherapy, which employs large amounts 
of drugs deleterious to both cancer cells 
and normal cells, will use minimal amounts 
of toxins directed only against the 
infected cells and virus.
Dr. de Noronha received his D.V.M. at 
the Escola Superior de Medicina Veterinar- 
ia, Universidade Technica de Lisboa, in 
Lisbon, Portugal, in 1950. He built a 
solid reputation as a veterinary research­
er and virologist while holding various 
positions in Spain, France, England, 
Germany, and his native Portugal. In 1964 
he joined the New York State College of 
Veterinary Medicine at Cornell as an 
Associate Professor of Virology, beginning 
the FeLV/FeSV studies that have occupied 
him nearly full time ever since. He and a 
Cornell research group were instrumental 
in isolating and identifying these feline 
retroviruses in the United States and 
establishing Cornell's Specific Pathogen- 
Free (SPF) Cat Colony of research animals 
to study feline diseases in vivo. Sus­
tained efforts to develop a vaccine for 
FeLV continue in his laboratory. Thirty- 
six scientific publications have resulted 
from Dr. de Noronha's important work here.
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Intraocular Inflammation in Cats 
as a Manifestation of Systemic Diseases
Thomas J. Kern, D .V .M ., D .A.C.V.O .
The normal gleam in a healthy cat's eyes 
may betray its devious personality, its 
predatory cunning, or its mischievous 
intent. Alterations in this appearance 
may foretell affliction with one of 
several feline systemic diseases long 
before changes in the cat's apparent 
health are obvious. To the observant cat 
owner and veterinary practitioner even 
subtle changes in appearance of a cat's 
eyes should prompt diagnostic pursuit.
The types of altered ocular appearance 
commonly noted by cat owners include:
1. Acquired, progressive change in iris 
color - especially if only one eye.
2. Progressive clouding in or on the eye 
(Figure 1).
3. Gradual loss of vision associated with 
either (1) or (2).
4. Gradual increase in eye size.
The ocular examination findings which 
parallel these owners' complaints include:
1. Acquired heterochromia: due to either 
iris pigment increase or loss.
2. Rubeosis iridis: new blood vessel 
growth on the anterior iris surface.
3. Dyscoria, with or without posterior 
synechiae.
4. Hypopyon.
5. Keratic precipitates: corneal endo­
thelial plaques of mononuclear inflam­
matory cells.
6. Cataract.
Fig. 1. C hronic active anterior uveitis in a cat, characterized by keratic 
precipitates, dyscoria, rubeosis iridis, and iris infiltration.
7. Flocculent anterior vitreal opacities.
8. Chorioretinitis.
9. Optic neuritis.
10. Chronic glaucoma.
Assessment of these findings should sug­
gest chronic active anterior and/or 
posterior uveitis. In most animal species 
of veterinary interest, uveitis is an 
infrequently manifested clinical sign of a 
myriad of systemic diseases, many of which 
defy clinical and laboratory diagnosis. 
However, two disease categories, infec­
tious and neoplastic, are responsible for 
a high percentage of documentable causes 
of feline uveitis.
All of the aforementioned changes are 
potentially visible to the naked eye of
5the pet owner or veterinarian. Surpris­
ingly, cats usually show minimal behavior­
al evidence of ocular discomfort, save for. 
occasional subtle behavioral alterations 
associated with diminishing vision. Usu­
ally, even a minor serous discharge from 
the eye is absent.
Infectious Diseases
Viral, parasitic, and fungal agents are 
potentially responsible for chronic feline 
uveitis.
FeMne infectious peritonitis (FIP), 
due to infection with a coronavirus, 
frequently boasts ocular complications. 
Even in the absence of clinical systemic 
signs of disease, unilateral or bilateral 
ocular signs are often prominent enough to 
impair vision or capture an owner's atten­
tion. Perivascular pyogranulomatous
inflammation causes a breakdown in the 
blood-aqueous barrier and leakage of 
fibrin and inflammatory cells into aqueous 
humor or vitreous. Retinal perivasculitis 
is infrequently noted as fluffy infiltra­
tion within the retina near blood ves­
sels. Choroidal inflammation frequently 
causes subretinal fluid exudation and 
secondary bullous or linear retinal 
detachments; solitary chorioretinal 
granulomas are infrequently recognized.
Toxoplasmosis is a significant cause of 
feline uveitis in endemic areas. Most 
often systemic signs of visceral toxoplas­
mosis are absent or vague at best. Dis­
crete iris or chorioretinal granulomas are 
infrequently noted. Active retinitis or 
chorioretinitis occasionally accompanies 
chronic anterior uveal inflammation.
Fungal agents responsible for the deep 
mycoses (histoplasmosis, blastomycosis, 
coccidioidomycosis, cryptococcosis) are 
also likely etiologic candidates in endem­
ic areas. Even in the apparent absence of 
visceral involvement, granulomatous 
anterior and posterior uveal inflammation 
may be fulminating or insidious. Discrete 
iris and chorioretinal granulomas are 
occasionally notable.
Neoplasia
Both primary and metastatic neoplasia may 
mimic chronic intraocular inflammation in 
clinical ocular presentation and course.
Primary uveal tumors in cats - mela­
nomas, cilicary adenomas and adenocarci­
nomas - usually present as readily recog­
nizable discrete uveal masses. Minor 
chronic inflammation associated with such 
neoplasms may ensue.
Metastatic neoplasms from primary 
tumors may exist as solitary uveal masses 
or diffuse infiltrative uveal lesions. 
Possibly the most frequently documented 
secondary intraocular tumor is multicen- 
tric lymphosarcoma. Metastatic feline 
sarcomas, mammary tumors, and adenocarcin­
omas have also been noted in the veteri­
nary literature.
Diagnosis
Diagnostic discrimination of these infec­
tious agents from one another or from 
applicable neoplastic disorders cannot be 
reliably made on clinical signs alone. 
While the spectrum of ocular clinical 
signs in an individual cat may typify one 
disease compared to another, these differ­
entiating characteristics are more concep­
tually than clinically accurate. All 
three infectious diseases as well as 
neoplasia must be considered and ruled out 
in every instance of chronic feline 
uveitis.
The diagnostic plan for such feline 
cases should include:
1. Complete physical examination.
2. Hemogram.
3. Feline leukemia (FeLV) test.
4. Coronavirus (FIP) and toxoplasma serum 
titers.
Documentation of high initial coronavirus 
or toxoplasma titers or serial rise in
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titer over the course of ocular disease 
progression or management may implicate 
the respective agent. A positive FeLV
test correlated with appropriate physical 
and hematologic findings may suggest
lymphosarcoma as the most likely ocular 
diagnosis. If physical examination, hema­
tologic, and serologic parameters are 
noncontributory to the diagnosis, further 
diagnostic evaluation is indicated.
The deep mycoses are difficult to 
document as etiologic agents. Chest 
radiography may demonstrate interstitial 
pneumonia. Anterior chamber paracentesis 
for cytologic examination and culture,
while ordinarily not indicated, in such 
instances may be the only method to 
document ocular fungal infection. As a 
last resort, serum titers for the fungal 
agents may cast suspicion toward one of 
them.
Other unusual infectious agents and 
immune-mediated disorders may rarely be 
associated with chronic uveitis in cats. 
Laboratory confirmation of these infre­
quent etiologies is considerably more 
difficult and less reliable than for the 
aforementioned disorders. For these
reasons, the more readily documentable 
etiologies are ruled out before the other 
disorders are investigated.
Treatment
Ideally, the two primary objectives of 
therapy for uveitis are: (1) to eliminate 
the associated systemic disease and (2) to 
prevent blinding ocular sequelae. Realis­
tically, therapy for FIP, toxoplasmosis, 
FeLV-associated diseases, and the deep 
mycoses is difficult and often unreward­
ing. For FIP, supportive therapy, perhaps 
in conjunction with judicious corticoster­
oid therapy, is indicated. Recommenda­
tions for toxoplasmosis treatment are 
available in current veterinary litera­
ture, but the available drugs appear to 
have limited success in eliminating the 
protozoan and may cause unacceptable side 
effects. Experimental usage of newer 
drugs, e.g., clindamycin and minocycline,
in laboratory animals may offer more
promising clinical results in the future. 
Cancer chemotherapy for FeLV-related 
syndromes may be a viable palliative
measure for selected feline patients. For 
deep mycoses, parenteral therapy with
newer, relatively safe fungistats like 
ketoconazole offers some hope for control 
and even cure.
Specific treatment for the systemic 
disease notwithstanding, specific ocular 
therapy is necessary to delay or prevent 
the blinding sequelae of chronic uveitis, 
e.g., secondary glaucoma, cataract, pupil 
seclusion, and retinal degeneration.
To reduce the chronic inflammation, 
topical corticosteroid-antibiotic medica­
tions should be used long-term and to 
effect. To preserve pupil integrity, 
topical 1% atropine therapy, also to 
effect, is indicated. This drug's cyclo- 
plegic effect ameliorates much of the 
ocular discomfort associated with 
uveitis. Chronic secondary glaucoma, a 
frequent insidious result of uveal inflam- 
maton, must be recognized early in its 
course to preserve vision as long as 
possible. In conjunction with topical 
corticosteroid appliaton, use of 0.5% 
timolol maleate (Timoptic® - Merck, Sharp, 
and Dome) SID to BID to reduce aqueous 
humor production is quite effective for 
intraocular pressure reduction.
With carefully monitored treatment, 
useful vision can very often be preserved 
on a long-term basis even when the 
underlying systemic disease cannot be 
eliminated.
Conclusions
Feline uveitis is a common clinical 
complaint, often unrecognized for its true 
significance as a harbinger of serious 
systemic diseases. The similarity of the 
ocular findings due to a myriad of causa­
tive agents and disorders precludes defin­
itive diagnosis of etiology. Clinical 
diagnosis must be corroborated by further
(Continued on page 8.)
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of companies have made lower priced echo­
graphs that are suitable for scanning 
cats, most of the less expensive 2-D units 
($10,000-$15,000) are designed for large 
animal reproductive scanning. These
latter echographs usually do not allow 
adequate resolution for studying struc­
tures as small as the inside of a cat's 
heart. At the present time it is cost- 
prohibitive for most practitioners to 
acquire an echograph capable of quality 
scanning the cat ($20,000-up). In the 
near future high quality instrumentation 
will probably be limited to teaching 
institutions and large, affluent referral 
practices. Other reasons for the limited 
use of ultrasound in the veterinary market 
are the technical expertise needed to 
obtain quality images and the training 
needed for accurate interpretation of the 
echograms.
With these substantial disadvantages to 
the expanded use of ultrasonography in 
veterinary medicine, why is it of any 
importance to the veterinary profession? 
Because knowledge of new technology is 
always essential for the advancement of 
medicine even when immediate acquisition 
of the technology seems impractical. The 
ultrasound units are now available at most 
referral veterinary institutions. Also, a 
liaison between veterinarians and human 
medical doctors in a community may provide 
a way that animals may be studied by 
ultrasound. In addition, with the rapid 
advancement of technology and the increase 
in competition between companies, perhaps 
in the next 10 years the cost of an echo­
graph will decrease. In time the price of 
an echograph may plummet just as the 
prices of calculators and computers have 
done over the past decade. Perhaps in the 
next 20 years an ultrasound unit will be 
as common in the private veterinary hospi­
tal as an electrocardiograph or X-ray 
unit.
The special training necessary for the 
operation of an echograph and interpreta­
tion of an ultrasonogram will not always 
be an obstacle, for once the enormous
advantages of ultrasonography are grasped 
and the price becomes affordable, an 
explosion of interest will spur the 
commitment for learning this valuable 
technology.
N. Sydney Moise (Tex '77), a Diplomate of 
the American College of Veterinary Inter­
nal Medicine, is a post-doctoral research 
fellow specializing in cardiology at the 
College of Veterinary Medicine, Cornell 
University.
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A  new  ultrasound unit (pictured ab ove) w ill be  
delivered to  the V eterinary C ollege in January, 1984, 
the gift o f  veterinary alum ni. (S ee  story on  page 8 .)
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New Ultrasound Unit Funded by Alumni Gifts
Thanks to our generous veterinary alumni, 
Cornell will soon have a multipurpose 
two-dimensional ultrasound unit. This 
unit will be used in both the small and 
large animal clinics, as well as for 
research. A gift of unrestricted funds 
from the alumni in Spring, 1983, made it 
possible to order this invaluable piece of 
equipment.
The unit (pictured on page 7) is a 
combination 2-D sector and M-mode echo­
graph with many features, including a 
videotape recorder for "instant replay," 
multiformat camera, integrated Polaroid®, 
ECG trigger, and biopsy guide. It will be 
equipped with four transducers of differ­
ent frequencies, each allowing a different 
depth of sound wave penetration and a 
varying degree of detail in the visual 
image produced. This feature makes the 
unit highly adaptable to both large animal 
use (which requires deep penetration 
through thick masses of soft tissue and 
relatively less acuity due to the large 
size of internal structures) and small 
animal use (which calls for shallower 
penetration and more intricate images, due 
to the minute size of internal struc­
tures ).
One of the characteristics that led to 
the choice of this particular unit is its 
capability of fine resolution of small 
structures, an important consideration at 
the Cornell Feline Health Center with 
respect to our feline cardiomyopathy 
studies. The new unit will allow detailed 
visual examination of the feline heart and 
cardiovascular system.
Delivery of the new ultrasound unit is 
scheduled for January, 1984. Because of 
its tremendous diagnostic potential, clin­
icians and researchers at the College are 
eagerly awaiting its arrival.
Intraocular Inflammation
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physical and laboratory examination. 
Finally, even when definitive therapy is 
unavailable or ineffective, symptomatic 
topical therapy is very often successful 
as a palliative measure.
Thomas J. Kern (Missouri '7b), a Diplomate 
of the American College of Veterinary 
Ophthalmologists, is an Assistant Profes­
sor of Medicine at the College of Veteri­
nary Medicine, Cornell University.
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